Prof. Wei R. Chen, co-inventor of IP-001, Stephenson Chair, professor, and interim director of the Stephenson School of Biomedical Engineering recently chaired the international conference, “Biophotonics and Immune Responses XX,” at the Photonics West Symposium, sponsored by the International Society for Optics and Photonics (SPIE). This year marks the 20th anniversary of the Biophotonics and...
Robert Arch, SVP Corporate Development at Immunophotonics, Inc. will be attending the BIO CEO & Investor Conference which will be held on February 10 -11, 2025 in New York at the Marriott Marquis. This event is among the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. This conference presents an...
Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics, Inc. will be attending the SIO2025 Annual Scientific Meeting January 30 to February 3, 2025, in Las Vegas, Nevada. Tomas will be connecting with interventional oncology professionals from around the world on the latest developments in improving cancer care alongside medical, surgical and radiation oncology to...
Tomas Hode, PhD, President & CIO will attend the SPIE, the international society for optics and photonics conferences taking place from January 25 to 30 in San Francisco. This event is one of the largest gatherings focused on photonics technologies worldwide. Tomas is excited to explore the latest advancements in photothermal therapy and nanomaterials relevant...
Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida. Some of the leading experts in the field of interventional oncology will be sharing their insights on the latest advancements in the fight against cancer at this esteemed even. Tomas is excited to connect with such talented...
Our networking is well underway with investors and potential strategic partners for JPM2025 in San Francisco, January 13 – 16, 2025. Attending the annual summit Tomas Hode at JPM Healthcare Conference, Robert Arch at JPM Biotech Showcase, and Theresa Visarius at RESI. They are looking forward to fostering connections and to discussing our recent accomplishments...
Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning and Networking (PLAN) webinar series. On Tuesday, November 19, from 3 PM to 4:30 PM (CST), they will share their insights and expertise in the session titled “CEO Perspectives on Launching & Growing Biotech Start-ups.”...
Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking place November 7th to 9th in Monte Carlo. They will engage with industry partners and clinical experts globally, focusing on the latest breakthrough technologies for surgical interventions. Look for Lu and Tomas at this event...
Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells” in Elsevier Cancer Letters an international journal providing a forum for original and significant contributions in cancer research. Click here to read the publication
Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug Development Summit held in Boston from September 30 – October 1, 2024. The program was highly informative, offering valuable insights, essential resources, and best practices for the development of immuno-oncology therapeutics. It also provided opportunities...
